ReviewInternational journal of molecular sciences2025
Microbial Nanoparticles in Biological Plant Protection.
Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanoparticles are small structures that differ in terms of their shape and composition; their high surface-to-volume ratio is responsible for their unique properties that make them perfect mediators for the delivery of substances. Nanoparticles do not only include metallic spheres but also complex polysaccharides capsule viruses or bacterial protein complexes (which can be considered bionanoparticles), which are 1-100 nm in size. Although nanoparticles are most widely studied from medical perspectives, their potential applications are almost limitless. One such promising use of functional nanoparticles is for plant protection against diseases. Although the precise use of nanoparticles decreases the need for the use of other chemical compounds, thanks to their increased product stability and delivery to a target site, the production of nanoparticles is often burdened by large quantities of toxic wastes. This problem can be limited if we apply the bioreactor green synthesis method, which includes the production of nanoparticles with the use of microorganisms. Bacteria can produce nanoparticles internally, externally, by only producing metabolites used for nanoparticle production directly, e.g., polysaccharides or surfactants, or indirectly as reducing agents for metal nanoparticle production. Regardless of the source of the nanoparticles, they can be widely used in processes from plant disease/pathogen detection to disease suppression. The endless variety of materials for nanoparticle production and the possible modifications that nanoparticles can be subjected to makes it impossible to predict how their structures will be used in the future. Nevertheless, in this study, we would like to turn attention to the fact that although nanoparticles are viewed as synthetic structures, they are ever-present in the microbial world and play an important part in intermicrobial interactions. As nanoparticle usefulness has been tested over years of co-evolution, it may be useful to look for potential future directions for this fascinating technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.